anti-BCLXL antibody product blog
Tags: Antibody; Polyclonal Antibody; BCLXL; anti-BCLXL antibody;
The BCLXL n/a (Catalog #MBS5300277) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s BCLXL can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB), Immunohistochemistry (IHC), Immunofluorescence (IF).WB: 1:500-1:1000
IHC: 1:50-1:100
IF:1:100-1:200. Researchers should empirically determine the suitability of the BCLXL n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the BCLXL antibody (Ser62) with the following immunoassay(s):
Immunohistochemistry (IHC) (Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using BCLXL antibody (Ser62))
Western Blot (WB) (Western blot analysis using BCL-XL (phospho- Ser62) antibody)
Rabbit Polyclonal BCLXL antibody (Ser62).
Biological Significance: BCLXL is an antiapoptotic member of the Bcl-2 family, it is located at the outer mitochondrial membrane and regulates outer mitochondrial membrane channel (VDAC) opening. Cross-Reactivity: Mouse, Rat
Immunogen: BCLXL antibody was raised in Rabbit using a synthesized phosphopeptide derived from human BCLXL around the phosphorylation site of serine 62 (A-D-SP-P-A) as the immunogen. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing BCLXL are readily searchable from our website. Different antibodies against the same target such as BCLXL may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.